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One of the biggest challenges in tumour research is the possibility to reprogram cancer cells towards less aggressive
phenotypes. In this study, we reprogrammed primary Glioblastoma multiforme (GBM)-derived cells towards a more differentiated
and less oncogenic phenotype by activating the Wnt pathway in a hypoxic microenvironment. Hypoxia usually correlates with
malignant behaviours in cancer cells, but it has been recently involved, together with Wnt signalling, in the differentiation of
embryonic and neural stem cells. Here, we demonstrate that treatment with Wnt ligands, or overexpression of b-catenin, mediate
neuronal differentiation and halt proliferation in primary GBM cells. An hypoxic environment cooperates with Wnt-induced
differentiation, in line with our finding that hypoxia inducible factor-1a (HIF-1a) is instrumental and required to sustain the
expression of b-catenin transcriptional partners TCF-1 and LEF-1. In addition, we also found that Wnt-induced GBM cell
differentiation inhibits Notch signalling, and thus gain of Wnt and loss of Notch cooperate in the activation of a pro-neuronal
differentiation program. Intriguingly, the GBM sub-population enriched of cancer stem cells (CD133þ fraction) is the primary
target of the pro-differentiating effects mediated by the crosstalk between HIF-1a, Wnt, and Notch signalling. By using zebrafish
transgenics and mutants as model systems to visualize and manipulate in vivo the Wnt pathway, we confirm that Wnt pathway
activation is able to promote neuronal differentiation and inhibit Notch signalling of primary human GBM cells also in this in vivo
set-up. In conclusion, these findings shed light on an unsuspected crosstalk between hypoxia, Wnt and Notch signalling in GBM,
and suggest the potential to manipulate these microenvironmental signals to blunt GBM malignancy.
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Glioblastoma multiforme (GBM) is the most common malig-
nant tumour occurring in the central nervous system, and one
of the most devastating human malignancies.1 A fraction of
GBM cells express markers typical of neural progenitor cells
(i.e., CD133, Sox2, Musashi1, Bmi1, and Nestin). In vitro, this
fraction of cells can be maintained as self-renewing population,
or induced to differentiate into multiple cell types, depending
on appropriate culturing conditions.2–4 These discoveries have
contributed to the notion that brain tumours arise from a
specific subset of cells defined as neural cancer stem cells
(CSCs).5 CSCs seem to be characterized by low rates of cell
division6 and high DNA repair capacity,7–9 features that may
explain their resistance to classical chemo- and radio-
therapies. Indeed, tumours relapsing after these treatments
recapitulate the heterogeneity of the original tumour mass.
Forcing differentiation of CSCs may represent a potential
effective therapeutic strategy. However, our limited under-
standing of the molecular pathways involved in their identity
currently frustrates this route. Wnt signalling has recently
been suggested to regulate differentiation of normal neural
progenitors, promoting neurogenesis in the murine adult
hippocampus,10 a hypoxic brain zone in which adult neural
stem cells (NSCs) reside.11 Hypoxia has been reported to
promote canonical Wnt signalling activation, enhancing NSC
differentiation and neuronal maturation by co-operating with
b-catenin activation.12 However, the possibility of an
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interaction between Wnt and the hypoxic signalling in the
context of brain tumours remains unexplored.
This study aimed to investigate the effects of Wnt pathway
activation on patient-derived GBM cells and stem-like cells
derived from them. In particular, we found that Wnt
activation promotes neuronal differentiation of GBM cancer
cells under hypoxia, and that these effects are exerted by
antagonizing Notch signalling, leading to: (1) upregulation of
pro-neuronal genes and (2) inhibition of stemness-related
pathways.
Results
Wnt activation promotes neuronal differentiation of
GBM cells. To study the effects mediated by exogenous
activation of Wnt pathway in GBM cells, we first analysed
cellular phenotype of primary GBM cells derived from the
dissociation of 10 tumour biopsies (grade IV gliomas) taken at
surgery (Supplementary Table S1), after recombinant Wnt3a
treatment (30 ng/ml for 96 h). Wnt3a significantly reduced the
percentage of CD133þ GBM CSCs (Figure 1a). Moreover,
GBM cells treated with Wnt3a, or transfected with a
constitutively active form of b-catenin (CA-b-catenin;
Supplementary Figure S1A), underwent a strong neuronal
differentiation and proliferation inhibition as shown by the
reduction of Nestinþ and Ki67þ cells and increased percen-
tage of neuronal-like b-III-tubulinþ cells (Figures 1b–e).
A significant increase in p21cip1 was also measured, indicative
of cell-cycle arrest (Supplementary Figure S1B). Induction of
neuronal differentiation was confirmed at the transcriptional
level by the upregulation of neuronal maturation and differ-
entiation markers NeuroD1, Neurog1, and b-III-tubulin
(Supplementary Figure S1C). To investigate whether the
observed differentiation mediated by Wnt was an irreversible
process, we treated cells with Wnt3a and analysed their
phenotype after its withdrawal. GMB cells showed no
reversion from the differentiated phenotype within 7 days after
Wnt3a withdrawal (Supplementary Figure S1D). We then
functionally validated the Wnt-induced differentiation by
analysing the sphere forming ability of GBM cells. We
measured a significant reduction in the number of neuro-
spheres generated after Wnt3a treatment (Figure 1f). More-
over, Wnt3a in vitro treatment significantly reduced the growth
of xenografts in vivo (Figure 1g). Indeed, xenografts derived
from Wnt3a-treated cells contained a reduced number of
CD133þ GBM CSCs (Figure 1h).
Interestingly, the effects of Wnt were observed in cells
maintained at 2% oxygen, a condition that is able to maintain
an undifferentiated phenotype per se.13 In normoxia (20%
oxygen), the Wnt-mediated effects were much less pro-
nounced: we found only a small decrease in the Nestinþ GBM
sub-population with a non-significant increase in b-III-
tubulinþ cells (Supplementary Figures S2A–C). Moreover,
the number of Ki67 and CD133 expressing cells did not
change in Wnt3a-treated cells at 20% oxygen (Supplementary
Figures S2D and E). These results suggested a key role of
hypoxia as a modulator of Wnt responsiveness in primary
GBM cells. We thus hypothesized that a hypoxic environment
could enhance Wnt-dependent GBM differentiation.
Hypoxia co-operates with Wnt in mediating GBM cells
differentiation. In our previous studies, we demonstrated that
microenvironmental hypoxia, through the oxygen-regulated
hypoxia inducible factor (HIF)-transcription factors,14 controls
GBM tumour physiology by modulating signalling pathways
involved in stemness maintenance and/or differentiation.15–17
To investigate the crosstalk between hypoxia and Wnt path-
ways, we transfected GBM-derived cells with a TCF/b-catenin-
activation (BAT-Lux) reporter plasmid, a well-established
sensor of Wnt activity.18 Cells were then treated with Wnt3a
ligand at different oxygen tensions. We found that hypoxia, but
not 20% O2, mediated a strong Wnt3a-induced b-catenin
transcriptional activation (Figure 2a). Conversely, Wnt had no
effect on HIF transcriptional activity, as assayed by transfection
of the HIF sensor (hypoxia response element (HRE)-LUC), in
line with the idea of HIF regulating Wnt, but not vice versa
(Figure 2b). To unravel the epistatic relationship between
HIF-1a and b-catenin, we silenced HIF-1a with lentiviral vectors
(about 78% silencing efficacy; not shown) in cells in which Wnt
pathway was activated at the intracellular level by inhibiting
GSK3 with the widely used inhibitor CHIR99021.19,20
CHIR99021 treatment upregulated b-catenin transcriptional
activity 4150 folds in control cells. Conversely, in HIF-1a
silenced cells, CHIR99021-mediated reporter induction was
significantly weaker (Figure 2c). These results suggest that
HIF-1a modulates b-catenin signalling by enhancing its
transcriptional activity downstream of GSK3 inhibition.
In embryonic and neural stem cells (NSCs), HIF-1a can
promote canonical Wnt signalling activation by overexpres-
sing b-catenin co-factors TCF-1 and LEF-1.12 For this reason,
we measured mRNA levels of TCFs in primary GBM cells.
Interestingly, we found that high oxygen levels strongly
reduced TCF-1/LEF-1 expression and augmented TCF-4
(TCF7L2) transcript (Figure 2d). Western blot (WB) analysis
confirmed the oxygen-mediated shift between TCF1 and
TCF4 protein levels (Figure 2e). Crucially, we found a
significant decrease in TCF-1 and LEF-1 mRNA expression
in HIF-1a silenced cells, indicating the specific involvement of
HIF-1a in the regulation of TCF-1/LEF-1 levels (Figure 2f).
Taken together, these data demonstrate that hypoxia
modulates Wnt pathway activation by controlling TCFs
expression through HIF-1a.
Notch signalling inhibition cooperates in Wnt-induced
differentiation. Wnt and oxygen levels are essential ele-
ments of the cellular microenvironment, but the cell-to-cell
contact, in a tumour mass is another fundamental feature
that determines cancer cell fate. Notch signalling attracted
our attention because of its dual activity as potent inhibitor of
neural differentiation and regulator of GBM stem cell
phenotype and aggressive behaviour.21
Blockade of Notch with the g-secretase inhibitor DAPT
induced a strong decrease in Ki67 expression and an increase
in b-III-tubulinþ cells (Supplementary Figures S3A–C).
Interestingly, growth arrest and neuronal differentiation
mediated by DAPT were comparable to that observed in
hypoxic Wnt signalling-activated cells (Supplementary
Figures S3A–C, compare it to Figures 1b–e). We thus
evaluated the possibility that Notch inhibition could
occur downstream of Wnt activation. For this reason, we
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Figure 1 Wnt3a modulates neuronal differentiation of GBM-derived cells. (a) Analysis of CD133 cell surface marker expression after Wnt3a treatment of GBM cells. Mean
of five tumours±S.E.M., n¼ 1 for each tumour. (b and c) Bar graph reporting relative quantification of immunofluorescence analysis on GBM cells treated with Wnt3a or
transfected with CA-b-catenin and stained for (b) Nestin/b-III-tubulin or (c) Ki67. Mean of six tumours±S.E.M. n¼ 3 for each tumour. (d and e) Representative images of
GBM cells treated as in (b) and (c) and stained for (d) Nestin (green)/b-III-tubulin (red) or (e) Ki67 (red). Bar¼ 100mm. (f) Representative images showing reduction in
neurosphere forming ability driven by Wnt3a treatment and relative graph. Bar¼ 200mm. (g) Growth kinetics of control or Wnt3a-treated GBM cells and injected
subcutaneously (5 105 cells) into both dorsolateral flanks in NOD SCID gamma (NSG) mice. Five mice per experimental group were used. (h) Cytofluorimetric measurement
of CD133þ cells derived from GBM xenografts at kill (8 weeks post injection). *Po0.05, **Po0.01, ***Po0.001
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transfected GBM-derived cells with a Notch activity reporter
(CBF1-luciferase) plasmid and evaluated Notch transcrip-
tional activation after Wnt3a treatment, or CA-b-catenin
transfection. Wnt activation caused a dramatic inhibition of
Notch transcriptional activity (Figure 3a), accompanied by
lower levels of Hes1 protein (Figure 3b), a primary target of
Notch, highly expressed in GBM cells. Moreover, we found
that Wnt3a-treated cells displayed increased levels of the pro-
neuronal markers Dll4 and Math1 (Figures 3b and c).22
We then sought to determine if Notch activation could
rescue Wnt effects in GBM cells. First, we attempted to rescue
the phenotype of Wnt3a-treated cells by co-administrating the
Notch ligand Dll4 and comparing their phenotype (as assayed
by Nestin and b-III-tubulin expression). Wnt3a-treated cells
retained a differentiated phenotype, irrespectively of Dll4
addition (Figures 3d and e). This suggested that Wnt/b-
catenin signalling operated downstream of Delta-Notch
binding. Interestingly, Wnt3a treatment – or CA-b-catenin
expression – reduced notch intracellular domain (NICD)
levels, a well-known read-out of Notch activation
(Figure 3b). We thus directly tested the effect of NICD
overexpression on Wnt activity by co-transfecting GBM cells
with expression plasmids encoding NICD and CA-b-catenin
(Supplementary Figure S4A). NICD overexpression partially
inhibited Wnt-mediated neuronal differentiation, as we found a
comparable decrease in the Nestinþ cells but a reduced
induction of b-III-tubulin (Figures 3f and g). Thus, we
concluded that Wnt opposes Notch signalling by intercepting
NICD activity. But how does b-catenin activation regulate
Notch? Numb and NumbL are well-known Notch inhibitors
and have been recently proposed to contain b-catenin binding
sites in their promoters.23 This prompted us to test whether
Wnt3a treatment was able to induce Numb and NumbL
transcription. As shown in Figure 3h, Wnt3a increased both
Numb and NumbL expression at the transcriptional and
protein levels. Moreover, chromatin immunoprecipitation
(ChIP) analysis showed that, under Wnt3a stimulus, b-catenin
directly bound to NUMB promoter, unveiling a direct
b-catenin-mediated upregulation of Numb (Figure 3i).
Coherently with the stronger b-catenin activation, also
Notch activity inhibition occurred mainly in hypoxic conditions
(Supplementary Figure S4B). These results indicate that the
Wnt/b-catenin axis has a direct effect on NUMB activation and
Notch signalling inhibition, consequently promoting GBM cells
differentiation.
Wnt activation affects the GBM stem-like cell population.
Data presented so far refer to the entire cell population
derived from GBM tumour mass, raising questions on what
cell population is affected by Wnt. To address this question,
we sorted primary GBM cells with fluorescent activated cell
sorting (FACS) by means of CD133 expression (not shown),
which is the better established GBM stem-like cell marker.4
Indeed, CD133þ cells were characterized by a higher
expression of markers associated with GBM stem cells such
as Sox2, CD4424 and CD9025 (Supplementary Figure S5A,
upper panels), comparable levels of glial acidic fibrillary
protein (GFAP) and b-III-tubulin expression (Supplementary
Figure S5A, lower panels), and a dramatic increase in their
neurosphere forming ability, when compared with CD133
cells (Supplementary Figure S5B).
We evaluated if there were differences in the response to
Wnt activation between CD133þ and CD133 cells. First,
we transfected CD133þ and CD133 sorted cells with the
Figure 2 Hypoxia modulates Wnt activation by regulating TCFs expression. (a) Bar graph representing luciferase reporter activity of BAT-lux transfected cells treated with
Wnt3a and cultured at 2% O2 or 20% O2. Mean of six tumours±S.E.M., n¼ 2 for each tumour. (b) Bar graph representing luciferase reporter activity of HRE-luc transfected
cells treated with Wnt3a and cultured at 2% O2 or 20% O2. Mean of six tumours±S.E.M., n¼ 2 for each tumour. (c) Bar graph representing luciferase reporter activity of HIF-
1a silenced and control (siLuc) cells, transfected with BAT-lux and treated with CHIR99021. Mean of three tumours±S.E.M., n¼ 2 for each tumour. (d) Real-time quantitative
polymerase chain reaction (RQ-PCR) analysis of TCF-1, -3, -4 and LEF-1 in GBM cells maintained in hypoxia or exposed to 20% O2 tension. (e) WB representing TCF-1 and
TCF-4 protein level in GBM cells at 2% or 20% oxygen tension. Analysis repeated on additional three tumours. (f) RQ-PCR analysis of TCF-1, -3, -4 and LEF-1 in GBM cells
silenced for HIF-1a or transduced with a control vector (siLuc). Mean of three tumours±S.E.M., n¼ 3 for each tumour. *Po0.05, **Po0.01, ***Po0.001
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Figure 3 Wnt pathway activation inhibits Notch signalling in GBM-derived cells. (a) CBF1-luc reporter analysis of Wnt3a-treated or CA-b-catenin-transfected cells
at 2% O2. Mean of four tumours±S.E.M., n¼ 2 for each tumour. (b) WB of protein extracts from same cells as in (a) displaying Notch pathway regulation. (c) RQ-PCR
analysis reporting relative expression of Dll4 and Math1. Mean of six tumours±S.E.M., n¼ 4 for each tumour. (d and e) Representative immunofluorescence images of GBM
cells treated with Dll4, Wnt3a or both for 96 h and stained for Nestin (green)/b-III-tubulin (red) (d) and graph reporting relative quantification (e). Mean of three
tumours±S.E.M., n¼ 3 for each tumour. Bar¼ 100mm. (f and g) Representative immunofluorescence images of GBM cells transfected with NICD, CA-b-catenin or
both, cultured for 48 h and stained for Nestin (green)/b-III-tubulin (red) (f) and bar graph reporting relative quantification (g). Mean of three tumours±S.E.M., n¼ 3 for each
tumour. Bar¼ 100mm. (h) RQ-PCR analysis showing mRNA levels of Numb and NumbL of Wnt3a-treated GBM cells at different time points (left). Numb and NumbL protein
expression of Wnt3a-treated or CA-b-catenin-transfected GBM cells (right). Mean of six tumours±S.E.M., n¼ 4 for each tumour. (i) ChIP analysis of Numb promoter
performed on 293T and GBM cells treated with Wnt3a or not treated. The IP was performed using anti-total b-catenin antibody or an irrelevant antibody as negative control.
*Po0.05, **Po0.01, ***Po0.001
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BAT-LUX or CBF1-LUC reporter constructs. Starting from a
comparable basal level of b-catenin transcriptional activity,
Wnt3a administration and CA-b-catenin overexpression
activated BAT-LUX reporter signal much more in the
CD133þ cells (Figure 4a). Moreover, Wnt3a and CA-b-
catenin inhibited Notch transcriptional activity only in CD133þ
cells (Figure 4b). These data suggest that Wnt pathway
activation is efficiently translated into b-catenin transcriptional
activation only in GBM stem-like cells. Phenotypic analysis
showed that Wnt activation promoted neuronal differentiation
mainly in CD133þ cells, which showed a strong increase in
the b-III-tubulinþ cell fraction (Figures 4c and d). As expected,
CD133 untreated cells displayed a more differentiated
phenotype relative to CD133þ cells (Figures 4c and d). In
agreement with these data, also proliferation was inhibited
only in CD133þ cells (Figures 4e and f).
The most pronounced Wnt3a-mediated differentiation
effect (and proliferation inhibition) was observed in CD133þ
Figure 4 Wnt activation-mediated differentiation mainly affects CD133þ GBM-derived cells. (a and b) BAT-lux (a) and CBF1-luc (b) reporter analysis of CD133þ or
CD133 sorted GBM cells treated with Wnt3a or transfected with CA-b-catenin at 2% O2. Mean of four tumours±S.E.M., n¼ 2 for each tumour. (c and d) Representative
immunofluorescence images of CD133± sorted GBM cells treated with Wnt3a for 96 h and stained for Nestin (green)/b-III-tubulin (red) (c) and relative quantification (d).
Bar¼ 100mm. (e and f) Representative immunofluorescence images of same cells as (c) and (d) stained for Ki67 (red) (e) and relative quantification (f). Bar¼ 100 mm. Mean
of four tumours±S.E.M., n¼ 3 for each tumour. *Po0.05, **Po0.01, ***Po0.001
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cells under hypoxia. Conversely, CD133 cells exposed to
20% oxygen were almost insensitive to Wnt3a treatment
(Supplementary Figures S6A and B).
Human GBM cells are subjected to Wnt signalling
activation when transplanted into zebrafish larvae. We
next sought to further validate the role of Wnt as promoter of
GBM cell differentiation. Previous reports showed that
growth of human tumours could be recapitulated in non-
murine models such as the zebrafish.26–28 Indeed, this
system presented several benefits in our context: first, it
allows live monitoring of GBM cell fate after injection; second,
developing fish brain expresses endogenous Wnt mole-
cules,29 whose activity can be visualized in vivo by using the
Wnt reporter zebrafish strain Tg(7xTCF-Xla.Siam:GFP)ia4;30
third, zebrafish embryos/larvae develop physiologically at low
oxygen tension;31 fourth, the unlimited amount of recipient
animals allows to carry out extended manipulations in vivo
before the emergence of cell culture senescence; fifth, the
availability of transgenic strains with an inducible expression
of the Wnt antagonist DKK allows to monitor the effect of
endogenous Wnt modulation on injected GBM cells.32
In light of the above considerations, we evaluated whether
GBM cell phenotype was affected by the zebrafish brain
microenvironment.29 By using the Wnt-reporter Tg(7xTCF-
Xla.Siam:nlsmCherry)ia4 strain (Figure 5a), we targeted
primary human GBM cell injection into a Wnt-rich brain site
located in the midbrain-hindbrain boundary, at 7 dpf
Figure 5 Xeno-transplanted GBM cells acquire a differentiated morphology. (a) Representative images showing mCherry expressing Wnt reporter zebrafish cells (red) in
the midbrain-hindbrain boundary at 2 dpf. (b) Xeno-transplanted primary GBM-derived cells (enhanced green fluorescent protein (EGFP) expressing; 4 hpi) in Wnt activated
midbrain hindbrain boundary of 7 dpf Wnt reporter Zebrafish larvae. Bar¼ 100mm. (c–f) Representative images of grafted EGFP expressing GBM cells in live larvae
monitored at 4 (c), 48 hpi (d), 96 hpi (e) and 35dpi (f). White arrows indicate the site where transplanted cells reside with  10 magnification and their cellular projections with
 40 magnification. Magnification  10, bar¼ 100mm; magnification  20 bar¼ 40mm; magnification  40, bar¼ 10mm
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(Figure 5b). Human GBM grafted cells were then tracked
in vivo until 35 days post injection (dpi). Live confocal imaging
performed 4 hours post injection (hpi), showed that GBM cells
were still characterized by a small, round morphology, typical
of undifferentiated brain tumour cells, and were localized at
the site of injection (Figure 5c). Intriguingly, starting from
48 hpi, GBM cells increased in size and exhibited cellular
projections first, and then axonal and neurite outgrowth
(Figures 5d–f).
We then assessed the direct involvement of Wnt pathway
activation in GBM transplanted cells. First, we found a
significant increase in total human b-catenin expression in
protein extracts obtained from grafted zebrafish brains,
starting from 48 hpi (Supplementary Figures S7A and B).
Second, by using the BAT-LUX reporter plasmid, we
registered an upregulated b-catenin transcriptional activity
in transplanted primary GBM cells at 24 hpi (Figure 6a, left).
Intriguingly, this occurred only in CD133þ cells (Figure 6a,
right), as previously shown in vitro. Moreover, by
transfecting tumour cells with CBF1-luc reporter plasmid,
we confirmed that zebrafish-mediated b-catenin activation is
accompanied by a concomitant decrease in Notch activity
(Figure 6b).
We characterized the differentiation of injected primary
GBM cell in paraffin-embedded zebrafish larvae. Immuno-
fluorescence analysis revealed a progressive loss of
Nestin and increase in b-III-tubulin expression, indicating
that the zebrafish brain induced a phenotypic shift of
transplanted GBM cells towards neuronal fate, as shown for
Wnt3a treatment in vitro (Figure 6c). In addition, expression of
microtubule-associated protein 2 (MAP2), a neuron-specific
cytoskeletal protein expressed in post-mitotic differentiated
neurons,33 progressively increased, confirming the
acquisition of a mature neuronal phenotype (Figure 6d).
Analysis of proliferation, through Ki67 staining, showed
that injected tumour cells progressively underwent mitotic
arrest (Figure 6e). We also found that mRNA levels of
genes related to neuronal differentiation (NeuroD1, b-III-
tubulin, and Neurog1) were upregulated in xeno-transplanted
GBM cells, confirming the pro-neuronal phenotypic shift
(Figure 6f) as shown in GBM cells after Wnt3a treatment
(Supplementary Figure 1C). Differentiation of cancer cells
should reflect in less aggressive tumours and to increase
survival of animal models. We thus evaluated fish survival
for up to 2 years, comparing GBM-injected zebrafish
with sham-injected or non-injected wild-type animals.
Human GBM cell injection did not affect survival (Figure 6g).
These results suggest that Wnt ligand-enriched zebrafish
brain is able to phenotypically reprogram transplanted GBM
cells in vivo, directing them towards neuronal differentiation
and mitotic arrest.
To functionally confirm in vivo the role of Wnt pathway
activation in differentiating human primary GBM-derived cells,
we transplanted cells into the zebrafish transgenic strain
Tg(hsp70l:dkk1-GFP), in which Wnt signalling can be
conditionally repressed by the overexpression of DKK1
(Supplementary Figure S8A).32 Strikingly, GBM cells, grafted
into Tg(hsp70l:dkk1-GFP) larvae, did not differentiate and
maintained their proliferation rate as shown by the expression
of Nestin, b-III-tubulin and Ki67 markers (Figures 7a–d;
compare it with wild-type embryos in Figures 6c and d). This
higher proliferation also correlated with a higher mortality of
injected larvae, when compared with sham-injected fishes
(Figure 7e). We obtained similar results in xeno-transplanted
larvae treated with IWR, a compound known to inhibit Wnt
pathway activation in vivo34 and able to downregulate the
expression of Wnt-controlled genes, such as neurod
(Supplementary Figures S8B and S9A–D).
These results confirm our in vitro observations and
indicate that endogenous Wnt signals in the vertebrate
brain can restrain GBM aggressiveness by fostering its
differentiation.
Gene expression profile of injected GBM cells demon-
strates induction of a less oncogenic phenotype. To
obtain further evidence on the involvement of Wnt-mediated
neuronal differentiation of GBM cells and to better character-
ize the phenotype of transplanted cells, we performed
whole genome profiling (GeneChip Human Genome U133
Plus 2.0) on grafted GBM cells. We analysed gene expres-
sion profile (GEP) of human GBM cells derived from two
different patients, each injected in 300 larvae. After 4, 24, and
48 hpi, we extracted total RNA from larval brain.
Eighty-nine probe sets were retrieved from the intersection
of the differentially expressed probe sets along the three time
points obtained by the two independent experiments
(Figure 8a; Supplementary Table S2). Specifically, we
found that transcription of KLF6 and KLF4, involved in
stemness and pluripotency maintenance,35,36 was decreased
after transplantation (Figures 8a and b; Supplementary Table
S2). Moreover, GEP data showed that injected GBM cells
underwent a dramatic decrease in c-JUN, VEGF, LDHA,
GAPDH, and ALDOA, indicative of a robust decrease in
proliferation, angiogenesis, and glycolysis related genes
(Figures 8a and b; Supplementary Table S2;
Supplementary Figure S10). Conversely, we observed over-
expression of the neuronal developmental genes GMP6B,
CRYAB, and NEFL (Figures 8a and b), in line with the Wnt-
dependent increase in Neurog1 and NeuroD1 observed
in vitro and in vivo (Supplementary Figure 1c; Figure 6f).
Finally, as a confirm, GEP validation comparison showed that
the same set of genes was activated in zebrafish-transplanted
Figure 6 Xeno-transplanted GBM-derived cells undergo neuronal differentiation and cell-cycle arrest. (a and b) BAT-lux (a) and CBF1-luc (b) reporter assays of human
GBM grafted cells (left: injection of entire GBM cell population; right: injection of distinct CD133þ or CD133 sorted GBM cell populations). Values are expressed in RLU
calibrated on non-transplanted GBM cells (0 hpi). Three different GBMs were analysed, n¼ 4 for each tumour. (c–e) Representative immunofluorescence images of paraffin-
embedded tissue sections of xeno-transplanted zebrafish larvae at 4, 48 and 96 hpi stained for (c) Nestin (green)/b-III-tubulin (red), (d) MAP2 (green)/b-actin (red), (e) Ki67
(green)/b-actin (red) (left panels) and bar graphs reporting relative quantifications (right panels). Bar¼ 40mm. For all graphs, mean of 10 tumours±S.E.M., n¼ 10 for each
tumour. (f) RQ-PCR analyses of NeuroD1, b-III-tubulin and Neurog1 expression normalized to Gusb and then calibrated to control cells (0 hpi) of human GBM cells grafted into
zebrafish nervous system, mean±S.E.M., comparing three different GBM, n¼ 4 for each tumour. (g) Survival graph of post-transplanted zebrafish compared with sham and
non-injected larvae bred in the same conditions. Mean of 10 tumours injected±S.E.M., n¼ 50 for each experimental group
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and in vitro Wnt3a-treated GBM cells (Figures 8b and c).
Indeed, this provides a robust proof-of-principle validation on
the use of zebrafish xenografts as in vivo surrogate or Wnt-
regulated in vitro differentiation.
Discussion
In the present study, we describe a Wnt/b-catenin-mediated
phenotypic reprogramming of patient-derived GBM cells
towards a neuronal-like fate. Moreover, we define the
fundamental role of hypoxia in enhancing the Wnt-mediated
neuronal differentiation and Notch inhibition. In particular,
we demonstrate a Wnt-regulated suppression of Notch
activity in the hypoxic microenvironment of GBM tumours
and the reduction of their stem-like cell sub-population
(CD133þ ). Several lines of evidence support these
conclusions:
(i) GBM cells treated with Wnt3a or transfected with CA-b-
catenin undergo a strong increase in b-III-tubulinþ
neuronal-like cells expressing high levels of NeuroD1
and Neurog1 (Figures 1b–e; Supplementary Figure 1c);
(ii) hypoxia promotes Wnt pathway activation through
HIF-1a-mediated TCFs modulation (Figures 2d–f);
Figure 7 Neuronal differentiation of grafted GBM cells is dependent on zebrafish Wnt ligands. (a and b) hsp70l:dkk1-GFP xeno-transplanted larvae at 4, 48 and 96 hpi
stained for Nestin (green)/b-III-tubulin (red) (a) and Ki67 (green)/b-actin (red) (b). Bar¼ 40mm. (c and d) Bar graphs showing relative quantification of images described in
(a) and (b). Mean of six tumours injected±S.E.M., n¼ 50 for each experimental group. (e) Survival graph of post-transplanted hsp70l:dkk1-GFP zebrafish compared with
sham±heat shock, bred in the same conditions. Mean of six tumours injected±S.E.M., n¼ 50 for each experimental group. ***Po0.001
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(iii) Wnt activation increases Numb and NumbL expression
whose function is to inhibit NICD activation (Figure 3);
(iv) Wnt-mediated differentiation and Notch inhibition
occurred mainly in the CD133þ stem-like GBM cell
population (Figure 4). Although CD133 has been shown
not to be unique in defining GBM or NSCs,37 it might be
used in combination with other markers to enrich cancer
cell populations for CSCs.38,39 Moreover, our data
support the idea that the CD133þ GBM sub-population
is enriched in cells with self-renewing capability and
stem-like features (Supplementary Figure S5).
The role of Wnt activation in regulating brain tumour
phenotype is controversial. Recent studies showed that the
use of GSK3 inhibitors, known to increase b-catenin levels,
potently and specifically blocked glioma cell migration,40
reduced tumorigenicity,41 and decreased stem cell markers
expression, such as Nestin and Sox2.42 However, many
authors reported that overexpression of Wnt in glioma tumours
promoted CSC self-renewal and proliferation.43,44 Indeed, many
pro-oncogenes promote GBM growth and stemness by activat-
ing Wnt pathway co-factors, in particular TCF-4.45–47 Consistent
with these data, we found that TCF-4 expression is higher in
GBM cells maintained at 20% oxygen (Figures 2d and e). That
said, our data are in agreement with the function of Wnts having
a more prevalent role as pro-differentiation factors, at least
under conditions that recapitulate the physiological hypoxic
microenvironment of the brain.48 Tissue oxygenation is a
fundamental parameter able to modulate the behaviour of
GBM cells and the activation of several cellular pathways.49
Mazumdar et al.12 recently reported that HIF-1a enhances the
expression of the b-catenin co-factors TCF-1 and LEF-1 in
embryonic and NSCs, thus promoting b-catenin-dependent Wnt
signalling activation. Our data confirm that HIF-1a mediates
TCF-1 and LEF-1 expression in primary GBM-derived cells
maintained under hypoxia (2% oxygen) and that this leads to
Figure 8 Gene expression profile of xeno-transplanted GBM cells and validation of data. (a) Heatmap resulting from microarray analysis of two independent experiments
of human GBM cells grafted into zebrafish nervous system at 4, 24 and 48 hpi. (b and c) RQ-PCR analyses of Dkk3, GPM6b, Jun, LDH-A, VEGF-A and KLF4 expression of
xeno-transplanted GBM cells normalized to Gusb, then calibrated to control cells (0 hpi) (c) and Wnt3a in vitro treated GBM cells (c). Mean±S.E.M. comparing two different
GBM, n¼ 4 for each tumour. (d) Cartoon describing the HIF-1a, b-catenin and Notch reciprocal regulations proposed in this study. *Po0.05, **Po0.01, ***Po0.001
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higher b-catenin transcriptional activity after exogenous Wnt
activation (Figure 2).
Interestingly, we found that the effects of Notch pathway
inhibition on GBM cells are comparable to that observed in
Wnt pathway-activated hypoxic cells (Supplementary Figures
S3A–C).21 Mechanistically, this is mediated by a direct
interaction between b-catenin and the promoter of NUMB in
Wnt3a-stimulated cells (Figure 3i), as previously suggested
by Katoh and Katoh23 based on bioinformatics. This result is
consistent with the Wnt-dependent suppression of NICD
activity observed under hypoxic conditions.
To confirm in vivo these results, we first validated and then
exploited the use of the small eleost Danio Rerio (zebrafish)
as paradigm of a natural brain parenchyma, particularly
enriched in Wnt molecules. The use of zebrafish as cancer
model system is not new: for example, Hendrix’s group
previously demonstrated that zebrafish microenvironment at
3 dpf suppressed the tumorigenic phenotype of xeno-
transplanted malignant melanoma cells.27,28 However, the
possibility to employ orthotopic injections in transgenic fish
brains for studying GBM is unique of the present study.
Interestingly, our in vivo data confirm that endogenous Wnt
signals operating in the developing zebrafish brain are able to
reprogram injected human GBM-derived cells towards a
quiescent neuronal phenotype. Injected cells show concerted
changes in the expression of stemness, proliferation, and
neuronal markers, as confirmed also by GEP analyses.
Moreover, these effects are inhibited in the hsp70l:dkk1-
GFP transgenic larvae where Wnt pathway is conditionally
ablated.
In conclusion, we describe the convergence of HIF, Wnt
and Notch pathways in the regulation of primary GBM-derived
cell differentiation (Figure 8d). Our data show that hypoxia has
a crucial role in preserving Wnt-ligand intracellular effects by
controlling the expression of b-catenin co-factors TCF-1 and
LEF-1. b-Catenin activation increases levels of Notch
inhibitors Numb and NumbL leading to the induction of pro-
neuronal gene expression. In addition, Wnt activation
promotes a dramatic differentiation of GBM cancer stem-like
cells towards a neuronal, less aggressive phenotype.
Materials and Methods
Isolation and oxygen controlled expansion of GBM cells. Written
informed consent for the donation of adult tumour brain tissues was obtained from
patients under the auspices of the protocol for the acquisition of human brain
tissues of the Ethical Committee Board of the University of Padova and Padova
Academic Hospital. All tissues were acquired following the tenets of the
Declaration of Helsinki. Patients from which we derived GBM primary cultures are
listed in Supplementary Table 1. GBM precursors were derived and maintained as
previously described15 in fibronectin-coated flasks. Where indicated, GBM-derived
cells were supplemented with soluble Wnt3a (30 ng/ml, Millipore, Billerica, MA,
USA) for 4, 24, 48 or 96 h or transfected by using a protocol for transient
transfection of adherent cells using Effectene Reagent (Qiagen, Hilden, Germany)
with a plasmid bearing a constitutively active form of b-catenin (CA-b-catenin)50 or
expressing the NICD.51 For the neurosphere forming assay, GBM cells were
plated in non-coated flasks at a density of 1000 cells/P12 well. Neurosphere
number was measured after 3 weeks of culture.
Flow cytofluorimetric analyses and CD133 cell sorting. Cells
(2 106 cells/ml) were incubated with anti-human b-III-tubulin, CD44, CD90 (Fitc;
BD Biosciences, Franklin Lakes, NJ, USA), CD133 (clone AC133/2-PE,
MiltenyiBiotec, BergischGladbach, Germany), Sox2 (PerCP5.5; BD Biosciences)
and GFAP (AlexaFluor647; BD Biosciences) as previously described.15,16,52
Viability was assessed by adding 7-amino-actinomycin-D (7-AAD, 50 ng/ml; BD
Biosciences) before analysis. Cells were analysed on a BD FacsAria III (Becton
Dickinson, Franklin Lakes, NJ) FACS. Relative percentages of different sub-
populations were calculated based on live gated cells (as indicated by physical
parameters, side scatter and forward scatter). Unlabelled cells and cells incubated
with appropriate isotype control antibodies were first acquired to ensure labelling
specificity. In cell sorting experiments, GBM cells were analysed and then sorted
on the basis of CD133 expression. A CD133 versus Side Scatter dot plot revealed
the populations of interest that were sorted: CD133þ and CD133 cell fractions
were selected by setting appropriate sorting gates.
Tumorigenicity assay. NOD SCID gamma (NSG) mice were purchased
from Charles River (Wilmington, MA, USA). Procedures involving animals and their
care conformed with institutional guidelines that comply with national and
international laws and policies (EEC Council Directive 86/609, OJ L 358,
12 December 1987). Eight-week-old male mice were used for experiments. For
tumour establishment, GBM cells were in vitro treated with Wnt3a (30 ng/ml for
5 days) and then injected subcutaneously (5 105 cells) in a 200-ml total volume
into both dorsolateral flanks. Cells were injected in combination with additional
200ml of Matrigel (Becton Dickinson). The resulting tumours were inspected
weekly and measured by calliper; tumour volume was calculated with the following
formula: tumour volume (mm3)¼ Lxl2 0.5, where L is the longest diameter, l is
the shortest diameter and 0.5 is a constant to calculate the volume of an ellipsoid.
After tumour formation, animals were killed, tumour mass was excised and
dissociated to single-cell suspension for cytofluorimetric analysis.
ChIP assay. We performed the ChIP assay on 293T and GBM cells treated
with 30 ng/ml of soluble Wnt3a for 48 h or maintained in culture medium as control.
Collected cells were sonicated 30 s for eight times in a water bath sonicator, and
immunoprecipitation was performed using total b-catenin antibody (rabbit, 1:5000;
Abcam, Cambridge, UK). Purification of genomic DNA (ChIP samplesþ input)
was performed by phenol/chloroform extraction, and we detected specific NUMB
promoter sequences from No Ab (negative control), immunoprecipitated (samples)
and input (positive control) DNAs by PCR, using 2ml of each DNA sample.
Zebrafish handling for xeno-transplantation. Zebrafish handling and
treatment were approved by the UniPD Ethical Committee on Animal
Experimentation (CEASA – Project #62/2009). GBM-derived cancer cells were
injected into the brain of 7 dpf wild-type or transgenic zebrafish larvae. During
injection, zebrafish were anaesthetized with Tricaine (0.5 mM 3-aminobenzoic acid
ethyl ester; Sigma-Aldrich, St. Louis, MO, USA) and then placed in a mini-plate
with multiple ramps. Zebrafish larvae were placed on their sides in 3% methyl-
cellulose. In some experiments, we transplanted GBM cells in hsp70l:dkk1-GFP
transgenic zebrafish larvae (gift from Dr. G. Weidinger). Heat shocks were
performed twice daily by transferring fish from 34 to 40 1C for 1 h.32 Wnt pathway
activation was evaluated in vivo by using the Tg(7xTCF-Xla.Siam:GFP)ia4 reporter
zebrafish line.30
Labelled cells were loaded into a pulled glass micropipette needle attached to an
air-driven micro-injector. The tip of the needle was inserted into the zebrafish brain
peri-ventricular zone, and intact cells were delivered in a double injection. We
optimized the number of cells injected in a range between 100 and 150 cells/shot
which we confirmed by dispensing cells onto a microscope slide and visually
counting them. The volume of material injected was B20–50 nl. At different time
points, zebrafish embryos were fixed using 4% formaldehyde in phosphate-buffered
saline (PBS) at 4 1C overnight, washed with PBS and then transferred to 70%
ethanol for subsequent paraffin embedding and immunofluorescence analysis,
dehydrated gradually into 100% methanol for in situ hybridization or dissolved in
TRIZOL Reagent (Invitrogen, Carlsbad, CA, USA) for RNA extraction.
Luciferase reporter assays on xeno-transplanted GBM cells.
GBM cells were transfected with BAT-luciferase reporter construct (BAT-Lux),
Notch-luciferase reporter plasmid (CBF1-LUC) and hypoxia-luciferase reporter
plasmid (HRE-Luc). Transfection with a Renilla luciferase vector was used to
normalize luciferase detection (Promega, Madison, WI, USA). Twelve hours after
transfection, total medium change was done, and cells were collected for zebrafish
injection. To control transfection efficacy, control cells were re-suspended in
passive lysis buffer (PLB, Promega) and luciferase activity was analysed.
Zebrafish xeno-transplanted larvae and GBM cells were processed for analysis of
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luciferase activity as recommended (Dual-Luciferase Reporter Assay System;
Promega) using a plate-reading luminometer (Victor; Perkin-Elmer, Waltham, MA,
USA). Values, expressed in relative light units (RLUs), were normalized to the
values obtained from non-injected GBM cells.
Gene expression profiling of xeno-transplanted cells. For micro-
array experiments, in vitro transcription, hybridization and biotin labelling of RNA
from zebrafish larvae brains were performed according to Affymetrix 3’IVT Express
protocol, before and at several time points after transplantation with GBM cells.
GeneChip Human Genome U133 Plus 2.0 (Affymetrix, Santa Clara, CA, USA) was used.
Microarray data (CEL files) were generated using default Affymetrix microarray
analysis parameters (Command Console suite software, Affymetrix). CEL files were
normalized using the robust multiarray averaging expression measure of Affy-R
package (http://www.bioconductor.org). Probe sets with Present or Marginal
detection calls in the zebrafish-only array, generated by the Affymetrix Microarray
Suite version 5 (MAS5, Affymetrix) algorithm, were filtered out in the analysis of the
arrays after transplantation.53 CEL files can be found at the Gene Expression
Omnibus (GEO) repository (http://www.ncbi.nlm.nih.gov/geo/; Series Accession
Number GSE25012), and are accessible without restrictions. Filtering on variance
(quantile 0.995) was applied to identify genes that were differently expressed along
the three time points (4, 24 and 48 hpi) in two independent experiments.
A heat map was generated using R software (http://www.R-project.org) using
Euclidean distance as a distance measure between genes.
Expression data have been deposited into the GEO database under Series
Accession Number GSE25012 and are accessible without restrictions.
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